For May 2021, we have selected: Walgaard et al. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial. Lancet Neurol 2021; 20=:275-283. doi: 10.1016/S1474-4422(20)30494-4.

COVID-19 around the World: Clinician interviews on experience and impact of the virus (Brazil)

COVID-19 around the World: Clinician interviews on experience and impact of the virus (India)

Many pregnant people in the United States have received mRNA COVID-19 vaccines, but data are limited on their safety in pregnancy. The authors of this study used data from the “v-safe after vaccination health checker” surveillance system, the v-safe pregnancy registry, and the Vaccine Adverse Event Reporting System (VAERS) to characterize the initial safety of mRNA COVID-19 vaccines in pregnant people.

The Ad26.COV2.S vaccine is a recombinant, replication-incompetent human adenovirus type 26 vector encoding full-length SARS-CoV-2 spike protein in a prefusion-stabilized conformation.

Individual registration for the EAN 2021 Congress is now back online, with a 10% discount available until May 10!

Greetings from Tropical and Geographical Neurology Specialty Group of World Federation of Neurology ! Please find attached the Program for  the fourth  session  of “Inspiring people in Neurosciences” to be held on 1st  May  2021.  Prof Angela Vincent will speak about Prof John Newsom Davis  while Prof… Continue Reading

The Brain Innovation Days team is very pleased to announce that registration is now open for the third Brain Innovation Days event, to be held virtually on 27 April 2021 at 12:30 – 14:00 CET.

EAN Student Task Force has decided to identify sessions which are recommended for undergraduate students as there is a significant increase in their numbers at the congress.

COVID-19 around the World: Clinician interviews on experience and impact of the virus (Kenya)

Combining an academic career with the clinical work is one of the many challenges faced nowadays by neurology resident and neurologist at the beginning of their career. As the number of clinician/scientists grows, the opportunities and potential paths one can choose is also growing exponentially.

The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study

International neurological organisations and regional umbrellas are teaming up to make neurology a global public health priority.

Clinical Fellowship Reports 2020

Impact of the COVID‐19 pandemic on stroke teleconsultations in Germany in the first half of 2020